Delivery Order SPE2DB20D1051-SPE2DB25FD8KU
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,040.65 firm fixed-price contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication. The contract has a completion date of May 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products, with a ceiling value of $1,348.08. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,245.69 and a performance period ending on June 26, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a prescription medication. The contract has a ceiling value of $4,936.67 and an ultimate completion date of September 17, 2024. It is a firm fixed-price contract without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication, with a ceiling value of $50,218.49 and a performance period ending on June 26, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $12,610.22, is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a medication used for diabetes management. The contract has a firm fixed price pricing type and an ultimate completion date of November 25, 2024. This contract is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,237.61, is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside and is an open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a diabetes medication. The contract has a firm fixed price of $2,768.40 and a period of performance ending on May 14, 2025. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,491.38 contract is for the supply of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes medication, with a performance period through June 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the Defense...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,076.30, is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a diabetes medication. The contract is a Firm Fixed Price (FFP) delivery order with a period of performance ending on May 20, 2025. Amerisourcebergen Drug Corp, a for-profit organization, has a significant Indefinite Delivery Contract...